KCNN4/KCa3.1 Blocking Peptide BLP-PC064 from Alomone Labs, Ltd.

Description

KCNN4/KCa3.1 Blocking Peptide (#BLP-PC064) is the original antigen used for immunization during Anti-KCNN4 (KCa3.1, SK4) Antibody (#APC-064) generation. The blocking peptide binds and 'blocks' Anti-KCNN4/KCa3.1 primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control

Product Specs
ItemKCNN4/KCa3.1 Blocking Peptide
CompanyAlomone Labs, Ltd.
Price Supplier Page View Company Product Page
Catalog NumberBLP-PC064
Size40 mcg
ApplicationsWB, IHC
FormatLyophilized powder
Purity>70%
TypeSynthetic peptide
NCBI Full Gene Namepotassium calcium-activated channel subfamily N member 4
NCBI Gene AliasesKCa3.1, rKCNN4c, rSK4
StorageShipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
TargetKCNN4
OriginIsrael/IL
Concentration0.4 mg/ml

Specifications/Features

starting price for North American orders, for exact pricing view product page

Sequence

RQVRLKHRKLREQV(C), corresponding to amino acid residues 350-363 of rat KCNN4

Add to Compare List

Alomone Labs, Ltd.

PO Box 4287

Jerusalem 91042

Israel

Phone: +972-2-587-2202
+972-2-587-1101

Company Profile

Website: http://www.alomone.com/

(1) Cooling‐induced cutaneous vasodilatation is mediated by small‐conductance, calcium‐activated potassium channels in tail arteries from male micePhysiological ReportsNovember 27, 2023Fumin Chang, Sheila Flavahan, Nicholas A. Flavahanwith SK3 or IK1 antibodies after being pre‐adsorbed with blocking peptides (catalog nos. BLP‐PC025, BLP‐PC064; Alomone), according to manufacturer's guidelines. Arteries were then rinsed in PBS (3 × 10 min) and

(2) Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse modelScientific reportsNovember 23, 2023Stransky N, Ganser K, Quintanilla-Martinez L, Gonzalez-Menendez I, Naumann U, Eckert F, Koch P, Huber SM, Ruth P.co-incubated with its specific blocking peptide (2 µg blocking peptide per 1 µg of antibody; Alomone labs, BLP-PC064). Patch-clamp recording. Macroscopic on-cell (cell-attached) and whole-cell currents from DMEM medium-grown

Be the First to Write a Review!